Basic Information
| LncRNA/CircRNA Name | SLC26A4-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:107653968-107662151 |
| Ensemble | ENSG00000233705 |
| Refseq | NR_028137 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | Microarray |
| Sample | PTC tissues |
| Expression Pattern | down-regulated |
| Function Description | SLC26A4-AS1 was expressed poorly in PTC. |
| Pubmed ID | 31556116 |
| Year | 2019 |
| Title | Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma. |
External Links
| Links for SLC26A4-AS1 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |